You are not logged in so some information on this page has been withheld. To see more, please log in.

Eli Lilly strikes $1.3 billion deal to buy gene-editing startup Verve Therapeutics, companies say

found 2025 › Jun › 17 (Tue) @ 11:25 UTC

Eli ■■
Lilly ■■
Verve Therapeutics ■■

Lilly has struck multiple partnership deals with gene-editing companies in the last two years to expand its portfolio beyond its weight-loss and diabetes drugs.